A Systematic Review to Define the Speech and Language Benefit of Early (<12 Months) Pediatric Cochlear Implantation

Hanneke Bruijnzeel1, Fuat Ziylan, Inge Stegeman

  • 1Department of Otorhinolaryngology and Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Insights

Early pediatric cochlear implantation (CI) before 12 months shows benefits in speech production, auditory performance, and receptive language. However, consistent evidence on all outcomes and the additional benefit of CI before 12 months is still lacking.

Area of Science:

  • Pediatric Otolaryngology
  • Audiology
  • Developmental Pediatrics

Background:

  • Early detection of hearing loss in infants is critical for optimal development.
  • Pediatric cochlear implantation (CI) is a treatment option for severe to profound hearing loss.
  • The optimal age for CI in infants remains a subject of ongoing research.

Purpose of the Study:

  • To evaluate the added benefit of pediatric cochlear implantation (CI) before 12 months of age.
  • To assess improvements in speech, language, and auditory development.
  • To synthesize current evidence on early CI outcomes.

Main Methods:

  • Systematic literature search of PubMed, EMBASE, and CINAHL databases.
  • Inclusion of studies with high directness of evidence (DoE) comparing different ages at implantation.
  • Assessment of speech perception, speech production, receptive language, and auditory performance.

Main Results:

  • Ten high DoE studies were included; six compared infants implanted before 12 months with those implanted between 12-24 months.
  • CI before 12 months showed benefits in specific speech production, auditory performance, and receptive language measures.
  • Evidence was inconsistent across all speech and language outcomes regarding the benefit of implantation before 12 months.

Conclusions:

  • Current evidence suggests early CI is beneficial, but lacks level 1 studies.
  • The additional benefit of CI specifically before 12 months is not consistently demonstrated across all outcome measures.
  • Long-term follow-up studies are needed to clarify the long-term advantages of very early pediatric CI.
Abstract